Skip to main content
. 2008 Jun 20;49(3):429–435. doi: 10.3349/ymj.2008.49.3.429

Table 3.

Diagnostic Value of Individual Parameters in Differentiating Malignant from Nonmalignant Ascites

graphic file with name ymj-49-429-i003.jpg

VEGF, vascular endothelial growth factor; Group 1, malignant ascites of chemonaive patients; Group 2, malignant ascites of chemotreated patients; CEA, carcinoembryonic antigen; CA19 - 9, carbohydrate antigen 19 - 9.